Aldawaa Medical Services Co. (DMSCO) reported a net profit of SAR 76.3 million for Q1 2023, down 12.5% from SAR 87.1 million in the same period last year.
Item | Q1 2022 | Q1 2023 | Change |
---|---|---|---|
Revenues | 1,294.82 | 1,407.59 | 8.7 % |
Gross Income | 494.18 | 534.98 | 8.3 % |
Operating Income | 70.71 | 116.00 | 64.0 % |
Net Income | 87.11 | 76.25 | (12.5 %) |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 1.02 | 0.90 | (12.5 %) |
Item | Q4 2022 | Q1 2023 | Change |
---|---|---|---|
Revenues | 1,458.30 | 1,407.59 | (3.5 %) |
Gross Income | 533.69 | 534.98 | 0.2 % |
Operating Income | 130.39 | 116.00 | (11.0 %) |
Net Income | 89.51 | 76.25 | (14.8 %) |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 1.05 | 0.90 | (14.8 %) |
The company recorded an 8.7% rise year-on-year (YoY) in revenue to reach SAR 112.8 million during the first quarter due to increased sales activities, own brands, and multi-channels.
Gross profit rose by 8.3% or SAR 40.8 million, YoY during the first three months.
Sequentially, Q1 2023 net profit fell 14.8% from SAR 89.51 million, due to the usual Q4 trend, which consists of seasonality and campaigns across multi-channels to support revenue momentum activities in Q4 2022.
Total shareholders’ equity, no minority interest, stood at SAR 1.076 billion as of March 31, 2023, from SAR 1.071 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}